Drug profile · INN
pentobarbital sodium
NEMBUTAL SODIUM
pentobarbital sodium (NEMBUTAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Drug details — pentobarbital sodium
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
pentobarbital sodium (NEMBUTAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pentobarbital sodium?
pentobarbital sodium (NEMBUTAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for pentobarbital sodium?
NEMBUTAL SODIUM is a marketed brand name for pentobarbital sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pentobarbital sodium?
pentobarbital sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.